NSUP
REGN icon

NLB Skladi upravljanje premozenja’s Regeneron Pharmaceuticals REGN Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
3,895
+752
+24% +$512K 0.09% 157
2026
Q1 		$2.43M Buy
3,143
+1,390
+79% +$1.06M 0.12% 140
2025
Q4 		$1.35M Buy
+1,753
New +$1.19M 0.06% 195

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NLB Skladi upravljanje premozenja's REGN Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja increased its Regeneron Pharmaceuticals (REGN) stake by 24% in Q2 2026, buying an estimated $512K and bringing the position to 3,895 shares worth $2.43M. The position accounts for 0.09% of the portfolio, ranked #157.

NLB Skladi upravljanje premozenja first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 1,330 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 3,895 shares of Regeneron Pharmaceuticals worth $2.43M as of Q2 2026.
  • NLB Skladi upravljanje premozenja bought 752 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $512K.
  • Regeneron Pharmaceuticals made up 0.09% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #157 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,330 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.